None listed
Conditions
Brief summary
Exercise induced muscle damage (EIMD) can lead to the condition known as delayed onset muscle soreness (DOMS). The neuromuscular changes that result from the pain and damage associated with DOMS can increase the risk of furthermore serious injuries. The pain and dysfunction from DOMS can peak at ~48hrs and can last for longer time in some cases which can result in significant lost training time and for new trainees can result in exercise drop out. This research project will investigate the effects of daily oral supplementation of Krill oil on improving muscle pain, muscle function, circulation of muscle damage markers, muscle swelling and sleep in 18–35-year-old healthy, untrained, and weight stable adults with sedentary lifestyle, while they undergo an 8-week supplementation of Krill oil. The project has been designed to test the hypothesis that 8 weeks of krill oil supplementation (4g/day) will reduce muscle pain, improve muscle function recovery and reduce markers of muscle damage when measured after EIMD in healthy, and untrained men and women and post exercise muscle soreness, menstrual pains and sleep quality will be improved during the study in participants taking Krill oil vs placebo.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
1-Aged 18-35 years, Males & females, 2-Healthy non-resistance trained (no structured resistance training in past 6 months), 3-Sedentary lifestyle, 4-Weight stable (no more than +/-2 kgs of weight change in last 2 months) adults.
Exclusion criteria
1- Aged <18 or > 35 years 2- Self-report as having had a musculoskeletal injury in the past 6 months, 3- Participation in structured resistance training in the past 6 months, 4- Allergies to any of the contents of fish oil or shellfish, 5- BMI <18.5 or BMI >27, 6- Currently participating in a weight loss program or special diet (e.g., Low carbohydrate, ketogenic, vegan etc), 7- Current smokers, 8- Acute or terminal illness, 9- Functional impairment that would limit inclusion in the trial, 10- Use of sports supplements or pain medication in the last month, 11- Current chronic disease including cancer, diabetes, cardiovascular disease, chronic liver disease, and gastrointestinal disorders that affects nutrient absorption, 12- Cognitive impairment or inability to commit to the study and its requirements or be randomised to their experimental group. 13- Known or family history of Bleeding disorders (haemophilia). 14- Connective tissue disorders (hypermobility, Ehlers Dalons syndrome etc)